O’Kane, Grainne M.
Leighl, Natasha B. http://orcid.org/0000-0002-8690-403X
Funding for this research was provided by:
Princess Margaret Cancer Foundation OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development.
Article History
First Online: 24 May 2018
Compliance with ethical standards
:
: Grainne M. O’Kane is supported by the Division of Medical Oncology/Hematology, Princess Margaret Cancer Centre, and Natasha B. Leighl is supported by the Princess Margaret Cancer Foundation OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development. No external funding support was provided for this review.
: Grainne M. O’Kane and Natasha B. Leighl declare that they have no conflicts of interest that might be relevant to the contents of this review.